Data as of Oct 22
| +0.55 / +1.71%|
The 3 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 30.00, with a high estimate of 33.00 and a low estimate of 27.00. The median estimate represents a -8.54% decrease from the last price of 32.80.
The current consensus among 4 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.